Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOW(R)-Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) and an isomer of (±)-ibuprofen (Item No. 70280).1 Unlike (S)-ibuprofen (Item No. 16793), (R)-ibuprofen does not inhibit COX-1 or COX-2 in vitro (IC50s = 360 and 15.6 µM, respectively) but is converted to the active (S)-enantiomer in vivo.2,3 It inhibits NF-κB transactivation in a reporter assay using Jurkat T cells (IC50 = 121.8 µM).1 (R)-Ibuprofen decreases superoxide formation and β-glucuronidase release induced by N-formyl-Met-Leu-Phe (fMLP; Item No. 21495), as well as leukotriene B4 (LTB4; Item No. 20110) formation induced by calcimycin (A23187; Item No. 11016), in human polymorphonuclear (PMN) cells (IC50s = 0.43, 0.58, and 0.22 µM, respectively).2 Formulations containing (±)-ibuprofen have been used in the treatment of fever and mild-to-severe pain.
WARNING This product is not for human or veterinary use.
1. Modulation of transcription factor NF-
2. Equipotent inhibition by R(−)-
3. The site of inversion of R(–)-